Health and wellness company Herbalife has agreed to acquire assets from Bioniq, marking a further step in its transition toward a data-led, personalized nutrition platform. The UK-based business develops individualized supplements designed to make health insights more accessible and actionable. The move builds directly on Herbalife’s 2025 acquisitions of Pro2col and Link BioSciences, extending its capability to deliver personalized nutrition through integrated technologies and data systems.
The combination is expected to bring together Bioniq’s biomarker-based formulation approach with Pro2col’s digital health application and Link BioSciences’ processing of biometrics, biomarkers, lifestyle data, DNA, and application-derived inputs. Herbalife states that these additions will enable it to provide a broader portfolio of customized supplements across multiple delivery formats, reinforcing its positioning in personalized nutrition at scale.
“The future of health and wellness is becoming more personalized and informed by data,” says Stephan Gratziani, Herbalife CEO. “By combining Bioniq’s personalized supplement technology with Pro2col and the power of our global distributor network, we are expanding our ability to deliver personalized wellness at a global scale.”
The transaction is expected to close in Q2 of 2026, subject to customary closing conditions and regulatory approvals. The company plans to introduce Bioniq’s solutions to customers in the US and select European markets later this year through its distributor network.
Bioniq’s platform combines a patented personalization framework, individual health data, and a proprietary biomarker database to generate supplement formulations suited to a wide spectrum of users, from general consumers to high-performance athletes. “I founded Bioniq in 2019 with a vision to help people optimize their well-being through a science-driven approach to nutrition that incorporates biomarker and lifestyle data,” says Vadim Fedotov, founder and president of Bioniq. “I am excited to join Herbalife with its global distributor network and commitment to advancing wellness at scale.”
Herbalife has also secured a call option to acquire Bioniz LAB, a platform focused on small molecules and peptides, enabling evaluation of longer-term opportunities. Cristiano Ronaldo, a nutrition partner of Herbalife and shareholder in Bioniq, supports the strategy. “Throughout my career, biometrics and personalized nutrition have been central to helping me perform and compete at the highest level,” says Ronaldo. “I’ve experienced firsthand how a tailored approach to nutrition can help optimize performance.” He adds, “I’m delighted to see Bioniq’s personalized supplements become part of Herbalife’s expanding access to nutritional supplements, helping people take a more informed approach to their health, wellness, and performance.”
The deal comes amid continued consolidation across the nutrition sector. Danone recently agreed to acquire Huel to expand its functional nutrition offering, while Lone Star Funds announced plans to acquire the Capsules & Health Ingredients division of Lonza Group. In parallel, Darling Ingredients and Tessenderlo Group combined collagen and gelatin operations into a new entity expected to generate US$1.5 billion in revenue.
